Andrew Redfern

Andrew Redfern is an Associate Professor of Medical Oncology at the University of Western Australia (UWA), holding roles as Associate Director for Clinical Strategy at the Harry Perkins Institute of Medical Research, Consultant Medical Oncologist at Fiona Stanley Hospital, and Medical Director of Linear Clinical Research. His primary affiliations include the UWA Medical School and the Department of Internal Medicine.

• Expertise: Medical Oncology, Clinical Trials, Translational Research
• Roles: Clinical Strategy Leadership, Early-Phase Human Trials, Cancer Biology Research

Research focuses on cancer growth signaling, chemotherapy/hormone therapy resistance mechanisms, tumor-stroma interactions, and Indigenous cancer biology. He leads clinical trials across all phases and chairs the State Breast Cancer Collaborative.

Recent articles emphasize advancements in prostate cancer treatment (e.g., PSMA-targeted therapies), bladder cancer AI diagnostics, and hormone therapy impacts on hepatocellular carcinoma.

Active in grants and collaborations, he leads projects on metastatic breast cancer therapies, epigenome engineering, and tumor suppressor exploitation. Over 25 grants highlight his translational research impact.